ID F420R_MYCTU Reviewed; 147 AA. AC O06553; L0T7G6; DT 02-NOV-2010, integrated into UniProtKB/Swiss-Prot. DT 01-JUL-1997, sequence version 1. DT 27-MAR-2024, entry version 135. DE RecName: Full=F420H(2)-dependent reductase Rv1155 {ECO:0000305|PubMed:27364382}; DE EC=1.-.-.- {ECO:0000269|PubMed:27364382}; GN OrderedLocusNames=Rv1155; OS Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv). OC Bacteria; Actinomycetota; Actinomycetes; Mycobacteriales; Mycobacteriaceae; OC Mycobacterium; Mycobacterium tuberculosis complex. OX NCBI_TaxID=83332; RN [1] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RC STRAIN=ATCC 25618 / H37Rv; RX PubMed=9634230; DOI=10.1038/31159; RA Cole S.T., Brosch R., Parkhill J., Garnier T., Churcher C.M., Harris D.E., RA Gordon S.V., Eiglmeier K., Gas S., Barry C.E. III, Tekaia F., Badcock K., RA Basham D., Brown D., Chillingworth T., Connor R., Davies R.M., Devlin K., RA Feltwell T., Gentles S., Hamlin N., Holroyd S., Hornsby T., Jagels K., RA Krogh A., McLean J., Moule S., Murphy L.D., Oliver S., Osborne J., RA Quail M.A., Rajandream M.A., Rogers J., Rutter S., Seeger K., Skelton S., RA Squares S., Squares R., Sulston J.E., Taylor K., Whitehead S., RA Barrell B.G.; RT "Deciphering the biology of Mycobacterium tuberculosis from the complete RT genome sequence."; RL Nature 393:537-544(1998). RN [2] RP IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RC STRAIN=ATCC 25618 / H37Rv; RX PubMed=21969609; DOI=10.1074/mcp.m111.011445; RA Kelkar D.S., Kumar D., Kumar P., Balakrishnan L., Muthusamy B., Yadav A.K., RA Shrivastava P., Marimuthu A., Anand S., Sundaram H., Kingsbury R., RA Harsha H.C., Nair B., Prasad T.S., Chauhan D.S., Katoch K., Katoch V.M., RA Kumar P., Chaerkady R., Ramachandran S., Dash D., Pandey A.; RT "Proteogenomic analysis of Mycobacterium tuberculosis by high resolution RT mass spectrometry."; RL Mol. Cell. Proteomics 10:M111.011627-M111.011627(2011). RN [3] RP FUNCTION, CATALYTIC ACTIVITY, AND BIOPHYSICOCHEMICAL PROPERTIES. RX PubMed=27364382; DOI=10.1002/pro.2975; RA Ahmed F.H., Mohamed A.E., Carr P.D., Lee B.M., Condic-Jurkic K., RA O'Mara M.L., Jackson C.J.; RT "Rv2074 is a novel F420H2-dependent biliverdin reductase in Mycobacterium RT tuberculosis."; RL Protein Sci. 25:1692-1709(2016). RN [4] RP X-RAY CRYSTALLOGRAPHY (2.2 ANGSTROMS) IN COMPLEXES WITH FMN AND PYRIDOXAL RP PHOSPHATE, AND SUBUNIT. RX PubMed=16239726; DOI=10.1107/s0907444905026673; RA Biswal B.K., Cherney M.M., Wang M., Garen C., James M.N.; RT "Structures of Mycobacterium tuberculosis pyridoxine 5'-phosphate oxidase RT and its complexes with flavin mononucleotide and pyridoxal 5'-phosphate."; RL Acta Crystallogr. D 61:1492-1499(2005). RN [5] RP X-RAY CRYSTALLOGRAPHY (1.8 ANGSTROMS), AND SUBUNIT. RX PubMed=15620716; DOI=10.1016/j.febslet.2004.11.069; RA Canaan S., Sulzenbacher G., Roig-Zamboni V., Scappuccini-Calvo L., RA Frassinetti F., Maurin D., Cambillau C., Bourne Y.; RT "Crystal structure of the conserved hypothetical protein Rv1155 from RT Mycobacterium tuberculosis."; RL FEBS Lett. 579:215-221(2005). RN [6] RP X-RAY CRYSTALLOGRAPHY (2.30 ANGSTROMS) OF 2-147 IN COMPLEX WITH COENZYME RP F420-2, FUNCTION, COENZYME F420-BINDING, AND SUBUNIT. RX PubMed=25644473; DOI=10.1002/pro.2645; RA Mashalidis E.H., Gittis A.G., Tomczak A., Abell C., Barry C.E. III, RA Garboczi D.N.; RT "Molecular insights into the binding of coenzyme F420 to the conserved RT protein Rv1155 from Mycobacterium tuberculosis."; RL Protein Sci. 24:729-740(2015). CC -!- FUNCTION: F420H(2)-dependent reductase able to catalyze the reduction CC of biliverdin-IXalpha to bilirubin-IXalpha in vitro. However, kinetic CC parameters show that it is less efficient than the biliverdin reductase CC Rv2074 and suggest biliverdin-IXalpha is unlikely to be the native CC substrate of Rv1155, which probably catalyzes the reduction of an CC alternative molecule in vivo (PubMed:27364382). Binds coenzyme F420, CC but does not bind FMN or other flavins (PubMed:25644473). Cannot use CC pyridoxine 5'-phosphate, pyridoxamine 5'-phosphate, pyridoxal 5'- CC phosphate (PLP), the anti-tuberculosis drug PA-824 or aflatoxin analogs CC as substrates (PubMed:25644473). {ECO:0000269|PubMed:25644473, CC ECO:0000269|PubMed:27364382}. CC -!- BIOPHYSICOCHEMICAL PROPERTIES: CC Kinetic parameters: CC KM=82.8 uM for biliverdin {ECO:0000269|PubMed:27364382}; CC Note=kcat is 0.024 sec(-1) for the reduction of biliverdin. CC {ECO:0000269|PubMed:27364382}; CC -!- SUBUNIT: Homodimer. {ECO:0000269|PubMed:15620716, CC ECO:0000269|PubMed:16239726, ECO:0000269|PubMed:25644473}. CC -!- SIMILARITY: Belongs to the F420H(2)-dependent biliverdin reductase CC family. {ECO:0000305}. CC -!- CAUTION: Was originally thought to be an FMN-dependent pyridoxine 5'- CC phosphate oxidase. {ECO:0000305|PubMed:16239726}. CC -!- CAUTION: FMN and PLP are seen in the crystal structures published in CC PubMed:16239726, however, the enzyme does not bind these compounds in CC vitro, and the complexes obtained in the crystal structures may be the CC result of weak FMN/PLP binding that is stabilized by the crystal CC lattice. {ECO:0000305|PubMed:25644473}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; AL123456; CCP43910.1; -; Genomic_DNA. DR PIR; D70555; D70555. DR RefSeq; NP_215671.1; NC_000962.3. DR RefSeq; WP_003898745.1; NZ_NVQJ01000025.1. DR PDB; 1W9A; X-ray; 1.80 A; A/B=1-147. DR PDB; 1XXO; X-ray; 1.80 A; A/B=1-147. DR PDB; 1Y30; X-ray; 2.20 A; A/B=1-147. DR PDB; 2AQ6; X-ray; 1.70 A; A/B=1-147. DR PDB; 4QVB; X-ray; 2.30 A; A/B=2-147. DR PDBsum; 1W9A; -. DR PDBsum; 1XXO; -. DR PDBsum; 1Y30; -. DR PDBsum; 2AQ6; -. DR PDBsum; 4QVB; -. DR AlphaFoldDB; O06553; -. DR SMR; O06553; -. DR STRING; 83332.Rv1155; -. DR PaxDb; 83332-Rv1155; -. DR DNASU; 885604; -. DR GeneID; 885604; -. DR KEGG; mtu:Rv1155; -. DR TubercuList; Rv1155; -. DR eggNOG; COG3467; Bacteria. DR InParanoid; O06553; -. DR OrthoDB; 1094370at2; -. DR PhylomeDB; O06553; -. DR BRENDA; 1.4.3.5; 3445. DR EvolutionaryTrace; O06553; -. DR Proteomes; UP000001584; Chromosome. DR GO; GO:0070967; F:coenzyme F420 binding; IDA:UniProtKB. DR GO; GO:0010181; F:FMN binding; IDA:MTBBASE. DR GO; GO:0016627; F:oxidoreductase activity, acting on the CH-CH group of donors; IBA:GO_Central. DR GO; GO:0042803; F:protein homodimerization activity; IDA:UniProtKB. DR GO; GO:0030170; F:pyridoxal phosphate binding; IDA:MTBBASE. DR GO; GO:0042816; P:vitamin B6 metabolic process; IDA:MTBBASE. DR InterPro; IPR019920; F420-binding_dom_put. DR InterPro; IPR011576; Pyridox_Oxase_put. DR InterPro; IPR012349; Split_barrel_FMN-bd. DR NCBIfam; TIGR03618; Rv1155_F420; 1. DR PANTHER; PTHR35176:SF2; F420H(2)-DEPENDENT REDUCTASE RV1155; 1. DR PANTHER; PTHR35176; HEME OXYGENASE HI_0854-RELATED; 1. DR Pfam; PF01243; Putative_PNPOx; 1. DR SUPFAM; SSF50475; FMN-binding split barrel; 1. PE 1: Evidence at protein level; KW 3D-structure; Oxidoreductase; Reference proteome. FT CHAIN 1..147 FT /note="F420H(2)-dependent reductase Rv1155" FT /id="PRO_0000399901" FT BINDING 32 FT /ligand="coenzyme F420-(gamma-Glu)n" FT /ligand_id="ChEBI:CHEBI:133980" FT /ligand_note="ligand shared between dimeric partners" FT /note="in other chain" FT /evidence="ECO:0000269|PubMed:25644473" FT BINDING 37 FT /ligand="coenzyme F420-(gamma-Glu)n" FT /ligand_id="ChEBI:CHEBI:133980" FT /ligand_note="ligand shared between dimeric partners" FT /note="in other chain" FT /evidence="ECO:0000269|PubMed:25644473" FT BINDING 50 FT /ligand="coenzyme F420-(gamma-Glu)n" FT /ligand_id="ChEBI:CHEBI:133980" FT /ligand_note="ligand shared between dimeric partners" FT /note="in other chain" FT /evidence="ECO:0000269|PubMed:25644473" FT BINDING 56..60 FT /ligand="coenzyme F420-(gamma-Glu)n" FT /ligand_id="ChEBI:CHEBI:133980" FT /ligand_note="ligand shared between dimeric partners" FT /note="in other chain" FT /evidence="ECO:0000269|PubMed:25644473" FT BINDING 77..79 FT /ligand="coenzyme F420-(gamma-Glu)n" FT /ligand_id="ChEBI:CHEBI:133980" FT /ligand_note="ligand shared between dimeric partners" FT /evidence="ECO:0000269|PubMed:25644473" FT BINDING 138 FT /ligand="coenzyme F420-(gamma-Glu)n" FT /ligand_id="ChEBI:CHEBI:133980" FT /ligand_note="ligand shared between dimeric partners" FT /evidence="ECO:0000269|PubMed:25644473" FT HELIX 6..15 FT /evidence="ECO:0007829|PDB:2AQ6" FT STRAND 18..25 FT /evidence="ECO:0007829|PDB:2AQ6" FT STRAND 31..37 FT /evidence="ECO:0007829|PDB:2AQ6" FT STRAND 39..41 FT /evidence="ECO:0007829|PDB:2AQ6" FT TURN 42..45 FT /evidence="ECO:0007829|PDB:2AQ6" FT STRAND 46..52 FT /evidence="ECO:0007829|PDB:2AQ6" FT HELIX 56..63 FT /evidence="ECO:0007829|PDB:2AQ6" FT STRAND 66..72 FT /evidence="ECO:0007829|PDB:2AQ6" FT STRAND 74..77 FT /evidence="ECO:0007829|PDB:1W9A" FT STRAND 79..85 FT /evidence="ECO:0007829|PDB:2AQ6" FT HELIX 98..110 FT /evidence="ECO:0007829|PDB:2AQ6" FT HELIX 117..126 FT /evidence="ECO:0007829|PDB:2AQ6" FT STRAND 129..135 FT /evidence="ECO:0007829|PDB:2AQ6" FT STRAND 138..142 FT /evidence="ECO:0007829|PDB:2AQ6" SQ SEQUENCE 147 AA; 16301 MW; DAF63639A04D6A0D CRC64; MARQVFDDKL LAVISGNSIG VLATIKHDGR PQLSNVQYHF DPRKLLIQVS IAEPRAKTRN LRRDPRASIL VDADDGWSYA VAEGTAQLTP PAAAPDDDTV EALIALYRNI AGEHSDWDDY RQAMVTDRRV LLTLPISHVY GLPPGMR //